| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 800 | - | - |
| - | - | 820 | - | - |
| - | - | 840 | ₹1.95 -39.06% | 75,950-10.90% |
| - | - | 850 | ₹2.75 -20.28% | 10,850-17.64% |
| - | - | 870 | ₹5.95 0% | 7750% |
| - | - | 880 | ₹5.3 1.92% | 27,125-27.08% |
| 7750% | ₹78.75 0% | 890 | ₹6.7 11.66% | 19,3750% |
| 3,1000% | ₹66.15 -3.43% | 900 | ₹8.85 14.19% | 83,70020% |
| - | - | 910 | ₹11.05 11.05% | 6,97550% |
| 1,5500% | ₹51.15 0% | 920 | ₹13.2 8.19% | 44,17516.32% |
| 55,8000% | ₹48 0% | 930 | ₹17.25 20.2% | 24,02510.71% |
| 27,125483.33% | ₹34.85 -7.31% | 940 | ₹20.4 13.33% | 1,66,625168.75% |
| 1,18,5756.25% | ₹28.95 -17.52% | 950 | ₹24.3 9.21% | 79,050-3.77% |
| 82,15047.22% | ₹24.6 -17.03% | 960 | ₹30 13.85% | 1,18,57575.86% |
| 49,60039.13% | ₹19.8 -19.18% | 970 | ₹36.1 15.15% | 50,37541.30% |
| 1,69,72525.14% | ₹16.5 -16.66% | 980 | ₹42.25 13.57% | 43,400-1.75% |
| 7,75042.85% | ₹13 -15.85% | 990 | ₹48 -1.74% | 4,650-25% |
| 4,11,5252.70% | ₹10.5 -24.18% | 1,000 | ₹46.8 0% | 83,7000% |
| 1,30,9753280% | ₹8.6 -21.81% | 1,010 | - | - |
| 27,1252.94% | ₹6.5 -23.97% | 1,020 | - | - |
| 34,10057.14% | ₹5.2 -25.71% | 1,030 | - | - |
| 44,1759.61% | ₹4 -29.82% | 1,040 | - | - |
| 25,575-2.94% | ₹2.95 -35.16% | 1,050 | - | - |
| 3,1000% | ₹4.35 0% | 1,060 | - | - |
| 25,5753.12% | ₹1.55 -32.6% | 1,080 | ₹95 0% | 5,4250% |
| 32,550281.81% | ₹1 -39.39% | 1,100 | ₹135.85 0% | 1,5500% |
| 12,4000% | ₹5 0% | 1,120 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
